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On a single-lead ECG, the activation of the ventricles dur-ing ventricular fibrillation (VF) appears to be highly 
complex and continuously changing, conjuring up the idea 
that VF results from random electric excitation. However, 
studies in animals1 and computational models2,3 in which elec-
tric wave propagation has been studied at high resolution have 
demonstrated that the characteristics of VF in the structurally 
normal heart are both deterministic and quantifiable, and that 
they depend on the activation rate of highly periodic reentrant 
sources that result in fibrillatory conduction with spatial gra-
dients of local activation frequency. Correspondingly, studies 
in humans using a relatively small number of body surface 
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Background— Ventricular fibrillation (VF) has been proposed to be maintained by localized high-frequency sources. 
We tested whether spectral-phase analysis of the precordial ECG enabled identification of periodic activation patterns 
generated by such sources.
Methods and Results—Precordial ECGs were recorded from 15 ischemic cardiomyopathy and 15 Brugada syndrome (type 
1 ECG) patients during induced VF and analyzed in the frequency-phase domain. Despite temporal variability, induced 
VF episodes lasting 19.6±7.9 s displayed distinctly high power at a common frequency (shared frequency, 5.7±1.1 Hz) 
in all leads about half of the time. In patients with Brugada syndrome, phase analysis of shared frequency showed a 
V1–V6 sequence as would be expected from patients displaying a type 1 ECG pattern (P<0.001). Hilbert-based phases 
confirmed that the most stable sequence over the whole VF duration was V1–V6. Analysis of shared frequency in ischemic 
cardiomyopathy patients with anteroseptal (n=4), apical (n=3), and inferolateral (n=4) myocardial infarction displayed 
a sequence starting at V1–V2, V3–V4, and V5–V6, respectively, consistent with an activation origin at the scar location 
(P=0.005). Sequences correlated with the Hilbert-based phase analysis (P<0.001). Posterior infarction (n=4) displayed 
no specific sequence. On paired comparison, phase sequences during monomorphic ventricular tachycardia correlated 
moderately with VF (P<0.001). Moreover, there was a dominant frequency gradient from precordial leads facing the scar 
region to the contralateral leads (5.8±0.8 versus 5.4±1.1 Hz; P=0.004).
Conclusions—Noninvasive analysis of ventricular tachycardia and early VF in patients with Brugada syndrome and ischemic 
cardiomyopathy shows a predictable sequence in the frequency-phase domain, consistent with anatomic location of the 
arrhythmogenic substrate.  (Circ Arrhythm Electrophysiol. 2015;8:1133-1143. DOI: 10.1161/CIRCEP.114.002717.)
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electrode recordings demonstrated spatiotemporal organiza-
tion during VF.4,5 However, it is still unclear whether highly 
periodic sources also maintain VF in humans and how they 
relate to the substrate in individual patients with distinct 
pathology.
As a first approximation, patients with Brugada syndrome 
(BrS) and ischemic cardiomyopathy (IC) may be considered 
to be 2 extremes of a continuum in which the structure of the 
ventricles changes from relatively homogeneous (BrS) to 
highly heterogeneous (IC), ie, whereas in BrS the ventricles 
are for the most part structurally uniform, in IC they are sub-
stantially remodeled, nonuniform, and variably scarred. Here, 
we study the possible mechanistic link between the ventricu-
lar substrate and the ensuing ventricular tachycardia (VT) and 
early VF in patients using a novel noninvasive analysis based 
on the standard precordial ECG leads. We tested the hypoth-
esis that early VF in patients with BrS or IC is spatiotempo-
rally organized by high-frequency sources localized stably 
at the pathophysiological substrate. We demonstrate that, in 
the human ventricles, the spatial location of the arrhythmo-
genic substrate yields a hierarchical organization in the phase 
and frequency domains that is consistent with a deterministic 
mechanism of fibrillation.
Methods
Detailed Methods are available in the Data Supplement.
Patients
Patients were admitted for electrophysiology study with either BrS 
type I ECG or IC with healed myocardial infarction (MI; >6 months). 
The study was approved by the Ethics Committee, and subjects gave 
informed consent.
Electrophysiology and Recording Protocol
Standard ECG was recorded continuously at a sampling rate of 1 kHz 
and band-pass filtered at 0.05 to 150 Hz. The electrophysiology strat-
egy varied according to the clinical indication.
Patients With BrS
We induced VF by programmed stimulation through a transvenous 
catheter electrode at the right ventricular (RV) apex or at the RV out-
flow tract. We included only those patients in whom the immediately 
preceding ECG displayed a type I pattern on the right precordial leads.
Patients With IC
Programmed RV apex stimulation was used for VT induction. We 
placed another catheter in the left ventricle (LV) for endocardial 
mapping and ablation as follows: 3-dimensional (3D) endocardial 
reconstructions were created by CARTO (Biosense Webster) map-
ping system delineating endocardial scar and dense scar tissues as ar-
eas displaying bipolar electrogram amplitudes of <1.5 and <0.5 mV, 
respectively.6 Ablation followed mapping of induced or spontaneous 
sustained VT. Sites displaying presystolic electrograms (within 50 
ms before the QRS onset) and fulfilling the criteria of concealed en-
trainment with equally spike-QRS to electrogram-QRS intervals were 
marked as the tachycardia exit sites. Pacing was performed for valida-
tion. For ethical reasons, the patients with IC included in the study 
were only those in whom sustained VF was unintentionally induced 
during the procedure.
Processing of Precordial Signals
Signals from precordial leads were exported, processed by a Hanning 
window and with a nonbiased 1 to 20 Hz band-pass filter. Thereafter, 
a 4096-point fast Fourier transformation (FFT; resolution 0.24 Hz) 
was obtained for frequency-phase analysis. Power and phase versus 
frequency were calculated for sliding episodes with 15-ms leaps. 
Dominant frequency (DF) was defined as the frequency with high-
est power in the spectrum. Shared frequency (SF) was defined as the 
frequency with power peak lasting >0.5 s simultaneously in all leads 
(Figure 1). The instantaneous phase was calculated by 2 methods: (1) 
the ratio of the imaginary to the real components of the FFT at the SF 
frequency and (2) the Hilbert transform of the entire episode.7
Location of the Pathological Substrates, Exit Sites, 
and Precordial Leads
In patients with BrS, the precordial signals displaying type I morphol-
ogy marked the location of the functional abnormalities.8 In a subset 
of 6 patients with IC, we merged computed tomographic scan images 
with the CARTO maps for better anatomic reference and marked the 
positions of the precordial ECG leads on the thorax surface by ac-
quiring the corresponding locations of a roving catheter tip on the 
CARTO (Figure I in the Data Supplement). We classified dense scars 
as those being located on the anteroseptal, apical, posterior, or infero-
lateral LV.
Computer Simulations
We used a realistic 3D computer model of the human heart and torso 
to simulate body surface potentials during ventricular pacing.
Statistical Analysis
Continuous variables are reported as mean±SD or as 95% confidence 
interval where noted. In case of a varying number of observations 
drawn from the subjects, the resampling methods of naive bootstrap9 
and the general bootstrap algorithm10 were used to make inferences 
(Data Supplement).
Results
Patients and VF
We studied early sustained VF in 15 patients with BrS and 
15 patients with IC (Table). We induced VF in patients with 
BrS by RV apex (n=14) or RV outflow tract (n=1) pacing. 
The IC cohort consisted of patients with previous MI of the 
WHAT IS KNOWN
•	The mechanisms of ventricular fibrillation in pa-
tients with and without structural abnormalities of 
the ventricles are poorly understood.
•	Phase and Frequency analyses of fibrillatory signals 
have elucidated arrhythmia mechanisms.
WHAT THE STUDY ADDS
•	During human ventricular fibrillation the spatial lo-
cation of the arrhythmogenic substrate implies a hi-
erarchical organization in the phase and frequency 
domain of electric activity recorded from the body 
surface that is not consistent with random cardiac 
activation.
•	The method and findings in this study pave the way 
to deriving further mechanistic insights from nonin-
vasive ECG recordings of ventricular fibrillation and 
tachycardia, with the potential to improve therapy.
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anteroseptal (n=4), posterior (n=4), apex (n=3), and inferolat-
eral (n=4) aspects of the LV. The IC patients included those in 
which VF was unintentionally induced while pacing from the 
RV apex (n=11), delivering antitachycardia pacing (n=2) or 
moving the catheters (n=2).
Precordial Frequency-Phase Domain Organization 
of VF in Patients With BrS and IC
Figure 1 shows sample VF data from a patient with BrS. The 
tracings in Figure 1A are simultaneous precordial lead record-
ings during sinus rhythm and induced VF. The sinus rhythm 
signals show a type I BrS ECG at V1 and V2 (left) indicat-
ing an abnormal arrhythmogenic substrate at the RV outflow 
tract.11 Figure 1B shows the power spectra of sliding periods 
of signals from V1–V6 during VF in the same patient. Despite 
signal variability in time and between leads, the periodogram 
of each precordial clearly shows narrow peak power at SFs of 
6.1 and 5.6 Hz. Overall, VF episodes recorded for 19.6±7.9 s 
in the 30 patients with BrS and IC contained 57 long-lasting 
epochs (3.4±2.1 s; range 0.7–8.7 s) of SFs corresponding to 
44.5±24.5% of the time through the whole spectrogram. In 
the other, 55.5% VF was characterized by power distributed at 
different frequencies on each precordial lead, possibly reflect-
ing more complex activity when compared with episodes with 
a SF. Both the duration and the number of SFs were similar in 
patients with BrS and IC (3.6±1.9 versus 3.3±2.2 s; P=0.591 
and 1.8±0.8 versus 1.7±0.9 s; P=0.667, respectively). The 
overall SF in all leads was 5.7±1.1 Hz; however, SFs in 
patients with BrS tended to be higher than patients with IC 
(6.1±0.7 versus 5.3±1.3 Hz, respectively; P=0.065).
We next investigated whether the VF activity recorded in 
the precordial leads maintained predictable phase sequences. 
Figure 2A shows the time-course of the phases at the 2 dis-
tinctive SFs in the 6 precordials in the same patient with BrS 
during the VF episode shown in Figure 1A. The phase distri-
bution (black arrow) and propagation (red arrow) between pre-
cordials occurred in well-demarcated clusters for the 57 SFs 
Figure 1. Shared frequency (SF) during ventricular fibrillation (VF) in a patient with Brugada syndrome (BrS). A, ECG tracings during SR 
(left, BrS type I at V1 and V2) and induced VF (right). B, Periodograms of 6 precordial signals. Despite temporal variability in A, all sig-
nals reveal simultaneous and relatively stable power at SF of 6.1 and 5.6 Hz for periods lasting several seconds. FFT indicates Fourier 
transformation.
Table.  Patients Characteristics
Patients With BrS 
(n=15)
Patients With IC 
(n=15) P Value
Age, y 42.9±11.6 66.2±8.5 <0.001
LVEF, % 62.6±2.6 41.8±9.8 <0.001
CHF 0 (0%) 2 (13.3%) 0.483
β-Blockers 0 (0%) 10 (66.7%) <0.001
Amiodarone 0 (0%) 3 (20%) 0.224
Sotalol 0 (0%) 1 (6.7%) 1.000
Class I 0 (0%) 0 (0%) *
Substrate location
  Anteroseptal 15 (100%) 4 (26.7%) …
  LV apex 0 (0%) 3 (20%) …
  LV inferolateral 0 (0%) 4 (26.7%) …
  LV posterior † 4 (26.7%) …
BrS indicates Brugada syndrome; CHF, congestive heart failure; Class I, class 
I antiarrhythmic therapy; IC, ischemic cardiomyopathy; and LVEF, left ventricular 
ejection fraction; and ns, not significant.
*Not computed.
†No ECG criteria.
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detected in patients with both BrS (27 SFs) and IC (30 SFs). 
The width of the clusters in those 57 sequences (measured 
by the length of the vertical black arrow) was 134.3°±46.2°, 
which was significantly narrower than a nonclustering dis-
tribution (P<0.001 versus 180° with similar SD; ie, a range 
including antiphases). The order of phases in the clusters var-
ied depending on the location of the specific arrhythmogenic 
substrate responsible for the arrhythmia. All patients with 
BrS were characterized by a type I ECG pattern with typi-
cal ST-segment elevation in V1 and V2, which corresponded 
to an anteroseptal location of the arrhythmogenic substrate. 
In these patients, the sequence of the phases (either distribu-
tion or propagation) was from V1–V2 to V5–V6 in 21 of the 
27 SFs (77.8%), whereas a sequence originating in V3–V4 or 
V5–V6 was observed in 2 (7.4%) and 4 (14.8%) SFs, respec-
tively (P<0.001). In Figure 2B, cumulative data show that the 
phases of V1 were of higher degree (early) in the cluster than 
V6 (late), with a monotonic decrease from right (V1) to left 
(V6; P<0.001) precordials, according to their location in the 
frontal axis (Figure I in the Data Supplement).
Because the sequence and phase distribution shown in 
Figure 1B are necessarily time-invariable by virtue of the FFT 
at a particular frequency (ie, the SF), we investigated the tem-
poral stability of the phases using also the Hilbert transform, 
which yields the instantaneous phase of the activity, consider-
ing the entire spectral content. Figure 2C shows the Hilbert-
based phases of the 6 precordial leads during the same VF 
episode as in Figure 1. Similar to the FFT-based phases, 
Hilbert-based phases clustered in well-defined groups. Most 
importantly, their temporal intrabeat sequence (ie, from V1 and 
V2 [early] to V5 and V6 [late]) was remarkably stable, which is 
in accordance with both the FFT analysis and the stability of 
the SF in this patient with BrS. Considering all patients with 
BrS together, the Hilbert-based phase sequences were found 
to be more frequently originating from V1 to V2 than from V5 
to V6 (88.9% versus 11.1%, respectively; P<0.001), showing 
substantial agreement with the sequence of FFT-based phases 
(Figure II in the Data Supplement ).
Precordial Phase Sequences During VF in Patients 
With IC
In patients with IC, the phase distribution and propagation 
of each of the 30 SFs during VF sequenced in relation with 
the location of the scar tissue in 63.3% (P=0.038). Figure 3 
shows VF data and phase analysis from an IC patient with a 
septal MI. As shown in A and B, early VF in that patient was 
characterized by an SF of ≈5.8 Hz. The time-course of the 
precordial phases shown in C demonstrates clustered activity 
Figure 2. Phase’s analysis during induced ventricular fibrillation (VF) in Brugada syndrome. A, The time course of phases of the sample 
precordials shown in Figure 1 is characterized by well-demarcated clusters. Black arrow, instantaneous phase distribution across leads; 
red arrow, phase propagation across leads. B, Cumulative fast Fourier transformation (FFT)–based phases at SF demonstrate a consis-
tent sequence from V1–V2 (early) to V5–V6 (late). Time for phase determination was at phase ≈0 in the middle of the cluster. Error bars: 95% 
CI. C, Hilbert transform provides the time course of phases for all frequencies. The phase distribution of the signals shown in Figure 1 
denotes a sequence from early to late (black arrow) similar to the FFT-based phases at specific SF shown in A. Time in all panels is mea-
sured from initiation of VF.
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with an intrabeat sequence of V1 (early) to V6 (late). In D, the 
intrabeat phase distribution across the precordials is displayed 
on the 3D torso map (Figures I–III in the Data Supplement) 
to confirm that the earliest beat-phase is at V1 (red), closest 
to the MI location, and the latest beat-phase is at V6 (purple). 
In Figure 4A and 4B, we use CARTO maps to illustrate 2 
additional examples of distinct relationships between the scar 
location and the distribution of precordial phases of SFs dur-
ing VF in patients with IC. In A, a patient with an inferolateral 
MI presented a VF episode with SF of 5.8 Hz and a V6–V1 
intrabeat phase sequence. In B, another patient with an LV 
apex MI developed VF with SF of 4.8 Hz with the earliest 
phase at V3–V4 and spread toward V1 and V6. However, the lat-
ter behavior was not representative of all patients with either 
LV apex or posterior LV MI, as the phase sequence varied 
substantially from one patient to the next. Figure 4C and 
4D shows phase distributions across the precordial leads of 
patients with anteroseptal and inferolateral scars. Data from 8 
SFs in 4 patients with anteroseptal scars showed a monotonic 
distribution from early V1 to late V6 (P<0.001; Figure 4C), 
consistent with the precordials location along the frontal axis. 
In contrast, Figure 4D shows that in 9 SFs from 4 patients 
with inferolateral scar the distribution of phases was such 
that V6 was earlier than V1 (P<0.001), V2 (P<0.001), and V3 
(P=0.048), with V1 having the lowest phases in the cluster`s 
alignment (P<0.001). The monotonic decrease of phases from 
V6 to V1 was not statistically significant when considering all 
precordials (P=0.245), probably because of large variability at 
V4. Yet the differences between lateral (V6) and right (V1, V2, 
and V3) precordial leads demonstrate that the distribution of 
phases reverses in patients with inferolateral scars relative to 
those with anteroseptal scars (see also below).
VF Phase Sequence and Wave Origin in Patients 
With IC
Figure 5A shows the location of the precordials (Figures I and 
III in the Data Supplement) relative to the heart to provide a 
geometric reference of the VF phase distribution across leads. 
In B, we show the FFT-based time-space plot of phases of SF 
in 3 sample VF cases with 3 different MI locations. The color-
coded phases (white arrows) are seen to propagate across leads 
(black arrows) in distinct sequences, consistent with what is 
shown in Figures 3 and 4: for anteroseptal and inferolateral 
MIs, the phases propagate from V1 to V6 and V6 to V1, respec-
tively, whereas for a LV apex MI, the phases spread from V4 
to V1 and V6.
To further validate the correlation between the precordial 
sequences and the ventricular origin of waves, we used a com-
puter model of the ventricles inside the torso to simulate paced 
activity and calculate the phase distribution on the precordial 
body surface locations. In Figure IV in the Data Supplement, 
pacing the septum, the LV apex, and the lateral LV yielded 
Figure 3. Ischemic cardiomyopathy; phases analysis during ventricular fibrillation (VF) in patient with a septal myocardial infarction (MI).  
A, Precordial signals during VF. B, Periodogram of V2 showing high power around 5.6, 6.3, and 5.8 Hz. C, The phase’s time course at 5.8 
Hz reveals a sequence from V1 to V6 (black arrow from early to late). The same alignment was observed for 5.6 and 6.3 Hz. D, Phase dis-
tribution superimposed on the thorax map illustrates that the sequence from V1 to V6 is consistent with activation originating close to the 
MI scar location (inset, red is <0.5 mV). FFT indicates fast Fourier transformation.
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similar sequences of phase propagation in the precordial leads 
as in Figure 5B, confirming our interpretation that the patterns 
of sequences depended on the directionality of ventricular 
wave propagation during VF.
To determine how precordial phase propagation patterns 
were affected by the scars exit sites, we performed simula-
tions in which we paced at opposite sides of conduction block 
lines representing scars similar to those of patients with IC in 
Figures 3 and 4. Figure VA in the Data Supplement shows that 
contralateral exit sites from scars that span 30% to 40% of the 
long axis of the LV and are located on the anteroseptal and 
inferolateral LV walls produce waves that move transiently 
in opposite directions, but subsequently follow propaga-
tion patterns that are similar for each block line, irrespective 
of the initial propagation direction. In Figure VB in the Data 
Supplement, phase propagation graphs are somewhat sensitive 
to the initial directionality of the exiting wave, but the sequence 
of the phases is mainly determined by the spatial location of the 
pacing site; ie, V6 and V5 precede other precodials when pac-
ing the lateral wall; V1 and V2 precede other precordials when 
pacing the septum. Thus, the sequence of precordial phases in 
the patients with IC analyzed in Figures 3 and 4 depends more 
on the scar location than on the precise exit site from that scar.
Because VF may contain frequency components other 
than SFs, each with its own phase sequence, we calculated the 
Hilbert-based phases of the precordial leads recorded during VF 
and compared their sequence with the FFT-based phase at the 
SFs contributing to the same ECGs. Figure 5C demonstrates 
that when all the frequency components of the 3 sample VF 
signals with similar MI location as in Figure 5B are considered, 
the propagation of phases remains generally similar to when 
only a single SF is considered. Further comparison of the leads 
at which the phases originated in the FFT-based phase analysis 
with those in the Hilbert-base analysis revealed a highly sig-
nificant concordance (ƙ concordance coefficient 0.741 [95% 
confidence interval, 0.497–0.938]), mainly when the origin was 
at V1–V2 or V5-V6 (Figure II in the Data Supplement). Overall, 
patients with anteroseptal, apical, and inferolateral LV MIs tend 
to display a steady sequence of phases originating at V1–V2, 
V3–V4, or V5–V6, respectively (Figures 3 and 4). Also, as shown 
in Figure VI in the Data Supplement, pacing from 2 different 
areas in the RV (outflow tract and apex; 5 patients) displayed 
different phase propagation patterns depending on the location 
of the stimuli and the direction of electric propagation.
Correlation Among Phase Sequences in VT and VF
We further tested the hypothesis that the arrhythmogenic sub-
strate in the ventricles determines the activation directionality 
during both VT and VF. We used paired comparisons between 
the mapped VTs and sustained VFs in the group of patients 
who developed both arrhythmias (n=10). As shown in Fig-
ure 6, phase propagation in VF was similar to VT in a patient 
with inferolateral MI. Figure 6A shows a monomorphic VT 
that subsequently transformed into VF. Despite the complex-
ity of the precordial VF signals in the time domain, the sam-
pled V1 and V6 periodograms in B reveal that a peak power 
Figure 4. Ischemic cardiomyopathy; phases during ventricular fibrillation (VF) and localized myocardial infarctions (MIs). A, Electroana-
tomic map showing an left ventricular (LV) inferolateral myocardial infarction (MI), sample VF recording and corresponding VF phases time 
course at shared frequency (SF) = 5.8 Hz. The earliest lead is V6. B, Electroanatomic map showing an LV apex MI, sample VF recording, 
and corresponding VF phases time course at SF = 4.8 Hz. The earliest lead is V4. C, Patients with anteroseptal scar display a steady 
sequence of propagation from V1 to V6. D, In contrast, inferolateral scar patients display a sequence from V6 to V1. Error bars, 95% CI.
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at SF ≈5.8 Hz is present for a significant portion of the VF 
episode analyzed. Figure 6C shows the phase analyses during 
VT (left) and VF (right) in the same patient. The phase propa-
gation sequence across the precordials was similar despite the 
different SFs that characterized each of the 2 arrhythmias; the 
sequence was from V6 to V1 in both.
Figure 7 summarizes the relationships among the sequences 
of the precordial phases during VF and VT. In A, data from 10 
patients show that the VT and VF phases at SF of the same 
leads correlate moderately but significantly (linear correla-
tion coefficient, 0.64; P<0.001). The relationship between the 
VT and VF phases is further quantified in B by a histogram of 
their differences (δ phase) along with the kernel distribution 
density estimation: the distribution of δ phase is well concen-
trated around a mean close to 0 (peak, −6.01; 95% confidence 
interval, −19.06, 5.57°), with 60% of the phases during VF 
being ≤30° different from the phases during VT in the same 
patient (95% confidence interval, 49%–71%). Figure 7C and 
7D illustrates the coarse relationship that exists between leads 
at which the phase originates during VT/VF and the location 
of the arrhythmogenic scar in patients with IC. The VT graph 
in C demonstrates that as the arrhythmogenic site shifts from 
the right (anteroseptal) to the middle (apex) and to the left 
(inferolateral) of the LV of different patients, a concomitant 
shift in the earliest VT phase of V1–V2, to V3–V4 and to V5–V6 
is observed (P<0.001). In D, the relationship between leads 
with the earliest phase and the site of the substrate during VF 
is less pronounced than in VT, mainly because the earliest lead 
is not uniquely determined for VF with apical and posterior 
substrate location. Nevertheless, when considering all the ana-
lyzed cases together, also during VF the earliest phases at the 
leads are significantly associated with the substrate location 
(P=0.005). Comparison between C and D leads us to conclude 
that the phase propagation of high-frequency periodicities dur-
ing VF is equivalent to the behavior of monomorphic VT phase 
propagation and its relation with the scar location.
On Hilbert-base phase calculation (Figure II in the Data 
Supplement) VF was characterized by a similar phase activ-
ity on the precordial leads as detected at SFs, which further 
established that the correlation between the substrate and the 
precordial phases is independent of the SFs. Finally, to con-
firm the tight geometric relationship between the sequential 
distribution of phases on the precordial leads and the arrhyth-
mogenic substrate, we compared their relative position on the 
body surface and on the heart. Angular analysis presented in 
Figure VII in the Data Supplement demonstrates a good cor-
relation between the azimuths of the precordial with earliest 
phase, the arrhythmogenic substrate, and the VT exit sites 
within a common short-axis plane of the torso.
Hierarchical Precordial DFs Localizes the 
Arrhythmogenic Area
The SFs across the precordials during VF were not necessar-
ily the DFs in the spectrogram for those leads; however, they 
were usually the DFs on the leads that were closest to the sub-
strate. Figure 8A shows power spectra of the precordials in an 
Figure 5. Propagation of precordial phases dur-
ing ventricular fibrillation (VF). A, Precordial leads 
diagram superimposed on a sample CARTO map 
of the left ventricular (LV) across the coronal plane. 
B, Dependency of the directionality of fast Fourier 
transformation (FFT)–based phase propagation on 
the location of the scar; in 3 sample patients the 
progression of the phase reverses from V1 to V6 
(left) to V6 to V1 (right) as the location of the scar 
changes from the anteroseptal to the inferolateral 
aspects of the LV. C, Equal sequences are obtained 
by Hilbert-based phases that account for all fre-
quency components of each signal.
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IC patient with inferior MI. A 5.85 Hz peak is present in the 
spectra of all leads, but it is the DF only at V5 and V6. It is the 
highest frequency peak among all leads and is located closest 
to the scar in this patient. To study the relationship between 
the hierarchy of the DFs and the location of the scar, we com-
pared the DFs in the leads near the scar and those in the con-
tralateral leads. Figure 8B summarizes the DF data in 11 IC 
patients with VF (patients with posterior scar were excluded). 
In 6 of 11 patients, a precordial DF gradient was observed 
between the scar and the contralateral locations. Considering 
all the patients with IC, with and without a gradient, we found 
the DF closest to the substrate to be higher than the DF contra-
lateral to the substrate (5.8±0.8 versus 5.4±1.1 Hz; P=0.004).
The precordial DF distribution in patients with BrS was 
found to be more uniform than the IC patients, with only 2 
of the 15 patients displaying a DF gradient (P<0.001). The 
SF value at each precordial was the same as the DF value, 
regardless of whether it was close to the substrate location (SF 
6.1±0.7 Hz versus DF 6.1±0.7 Hz; P=0.327) or more distally 
(SF 6.1±0.7 Hz versus DF 6.1±0.7 Hz; P=0.476). Obviously, 
at a mean uniform value of 6.1 Hz, a DF gradient in our BrS 
cohort is nonexistent (P=0.648).
Cardiac Function and VF Dynamics
Interestingly, the cardiac function of patients during sinus 
rhythm was related to electric dynamics during VF. Consid-
ering the precordial DF values during VF, both BrS and IC 
patients with no DF gradient had higher LV ejection frac-
tion (60.6±8.9%; n=18) than patients with a DF gradient 
(44.7±14.7%; P=0.002; n=8; Figure 8C). As expected, patients 
with BrS had no cardiac structural abnormalities as quantified 
by echocardiogram. In patients with IC, we observed a trend 
toward significantly higher LV ejection fraction in patients 
with no DF gradient (49.2±10.6%) than in those with a DF 
gradient (38±9.1%; P=0.091). Lack of statistical significance 
at P<0.05 in the patients with IC is because of low power, pos-
sibly related to their generally lower LV ejection fraction than 
that in the patients with BrS, requiring further study.
Discussion
The main findings of this study are that the signals of the 6 
precordial ECG leads during VT and VF in patients with BrS 
and IC follow a sequence in the phase-domain that is dis-
tinctly related to the location the pathophysiologic substrate. 
Using frequency-phase domain analysis across the standard 
precordial leads, we demonstrate hierarchical distributions 
of frequencies and phases suggesting that in many individual 
patients the arrhythmias are driven from a substrate location, 
with higher source frequency in VF versus VT. Thus, our 
results are consistent with a nonrandom mechanism of VF 
and support the idea that a relatively small number of stable 
sources maintain VF in both the structurally normal and the 
diseased human heart.
Figure 6. Phase distribution during ventricular tachycardia (VT) and ventricular fibrillation (VF) in an ischemic cardiomyopathy patient. 
A, ECG tracings during VT (left, frequency of 3.2 Hz) and VF (right) in a patient with an inferolateral scar. B, The periodogram during VF 
shows that 5.8 Hz is the highest frequency to contain significant power for most of the recording time in V6 and V1. C, Phase propagation 
sequence is similar for VT at 3.2 Hz and VF (shared frequency) at 5.8 Hz (V6–V1).
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Deterministic Activation During Fibrillation
Early experimental studies in structurally normal rabbit and 
guinea-pig hearts demonstrated stable and fast rotors driving 
VF1,12 and generating high-frequency waves interacting with 
the surrounding myocardium giving rise to fibrillatory con-
duction and irregular ECG.13,14 In the structurally normal heart 
of the sheep, fibrillatory conduction is reflected as excitation 
organized in DF domains connected by Wenckebach-like con-
duction block patterns at their boundaries.15 In both animals16 
and humans,17 the DFs of excitation waves have been found 
to underlie the frequency domain of specific ECG leads on 
the thorax. During VF in our patients, there were both surface 
spectral components in the form of SF across the precordial 
leads and sequential phase distributions (Figures 6 and 7) that 
were consistent with patterns of waves arising from a region 
containing an arrhythmogenic substrate (Figures III and IV in 
the Data Supplement).
Our findings are consistent with the pioneering work of 
Clayton et al4,5 who analyzed VF recordings and found a simi-
lar frequency content at 3 ECG orthogonal leads 58% of the 
Figure 7. Phase sequences in ventricular fibril-
lation (VF) and ventricular tachycardia (VT). A, 
Correlation between VT and VF phases in similar 
leads in 10 patients. Time for determination of 
phase distribution was selected as the time when 
the earliest lead was at ≈120°. B, Histogram (bin 
= 20°) of the differences between the VF and the 
VT phases (δ phase) of data from A along with the 
kernel distribution density estimation (see text). C, 
Origin of VT phase sequence and the exit site or 
the arrhythmogenic scar in ischemic cardiomyop-
athy (IC) patients: the phase origin reverses from 
V1–V2 to V5–V6 as the exit site of the VT changes 
from the anteroseptal (right) to the inferolateral 
(left) aspects of the left ventricular (LV). D, Origin 
of VF phase sequence in IC patients displayed 
similar dependency of phase origin on site of 
LV substrate as in VT in C. SF indicates shared 
frequency.
Figure 8. Dominant frequency (DF) gradient at precordials during ventricular fibrillation (VF). A, Representative example of DF gradient 
in a patient with ischemic cardiomyopathy (IC). Power at a shared frequency (SF) of 5.85 Hz is noted. However, this frequency is domi-
nant only at V6 and V5 and lower frequencies are dominant in the other precordials; the lowest DF of 3.17 Hz is in V1. B, DF during VF in 
patients with IC (n=10; 18 SF) shows statistically higher values in precordial leads closest to substrate location. C, LV ejection fraction 
(LVEF) was significantly higher in patients without (n=18) than with (n=8) a DF gradient.
 by guest on August 18, 2016http://circep.ahajournals.org/Downloaded from 
1142  Circ Arrhythm Electrophysiol  October 2015
time, with small variability in the phase relationship between 
leads.
Others have found rotors in the human ventricle under dif-
ferent conditions.18,19 However, whether these highly periodic 
sources drive the spatiotemporal organization that we found in 
our patients or simply coexist as epiphenomena embedded in a 
multiple-wavelet self-sustained system remains controversial. 
Recently, Bradley et al20 studied in vivo human VF and found 
that the global ischemia produced by the arrhythmia decreased 
DFs while increasing the number of wavebreaks, the hallmark 
of rotor formation. Consistent with our study, Nair et al19 used 
plunge needles in Langendorff-perfused human hearts and 
identified 3D rotors during early VF to localize in regions of 
greater intramural fibrosis.
Regional Ischemia and Organization of VF
Experimental studies have demonstrated that the epicardial 
border zone of the myocardial scar is prone to sustain reen-
trant sources of fast VT in animal models.21 Coromilas et al22 
confirmed that dynamic anisotropy in the periphery of the scar 
supports short-cycle reentry after action potential shortening 
by pinacidil. In a pig model of regional ischemia, Zaitsev et 
al23 reported that the distribution of wavebreaks during VF is 
particularly high at the border zone, which exhibits also the 
largest heterogeneity of excitation frequencies, including high-
est local DFs. Although no sustained reentry driving VF was 
registered in those studies, the conjecture was that the wave-
breaks in the border zone contributed to the VF by providing 
a perpetuation mechanism for source formation and mainte-
nance. Overall, the regional scar and ischemia conditions in 
the experimental studies reflect the importance of particular 
myocardial areas in facilitating reentry during fibrillation,24–26 
giving credence to the idea that regular firing sources at the 
periphery of the scar drive VF in our patients.
Local high-frequency periodicity during VF points to a 
potential driver location similar to that observed during mono-
morphic VT at a slower frequency.15 Because mapping and 
ablation determined that the exit site of the VT was closely 
related to the scar, we suggest that periodicities observed dur-
ing VF reflect centrifugal activity from a similar scar region. 
Previous studies in human hearts demonstrated that fibrosis 
increased wavebreaks and turbulent propagation, but also 
stabilized reentry.19,27 Our data demonstrate that an intraven-
tricular DF gradient exists during early VF in patients with the 
lowest LV ejection fraction during sinus rhythm (Figure 8). 
These observations support the notion that VF in our patients 
originates from high-frequency sources localized to a regional 
arrhythmogenic substrate and further include widespread, 
slower fibrillatory activity.
Limitations
All VF episodes were induced and therefore the mechanisms 
identified may not apply to spontaneous VF. However, simi-
lar to the atria, induced VF likely mimics spontaneous VF.28 
Some patients with IC were under β-blocker treatment, which 
could have converted their VF to be driven by a single source.29 
Nevertheless, the fact that similar sequences of phases were 
observed during VF in patients with BrS that were devoid of 
β-blockers suggests that the location of the VF source(s) in all 
patients was related to the location of their scar. As for the data 
acquisition, the small number of electrodes and their position 
on the body surface limit the sensitivity of our analysis for 
possible complex activation patterns and may bias toward 
a localized source mechanism of VF. In addition, the nonu-
niqueness of the relation between epicardial potentials and the 
myocardial waves limits our interpretation. Indeed, scarcity 
of intracardiac data precludes exclusion of scenarios in which 
there is no relationship between origin of VT/VF waves and 
precordial sequences. However, the match between epicardial 
and nearest body surface potentials demonstrated by Burnes 
et al,30 as well as the fact that both patients and simulations 
demonstrate a clear relationship between pacing sites and the 
precordial sequences, diminishes the impact of such limita-
tions. Finally, despite significant positive relationship between 
phases and scar locations in patients with anteroseptal and 
inferolateral scars, the configuration of the 6 precordials 
precluded us from establishing specific phase sequences in 
patients with either LV apex or posterior LV MI.
Conclusions and Clinical Implications
Ablating substrates to prevent VT31 and VF11,32 recurrences in 
humans is now common. Here, we demonstrate that early VF 
in patients with BrS and IC is characterized by a reproducible 
phase sequence in the precordial leads consistent with waves 
originating from the location of the arrhythmogenic substrate. 
In addition, we demonstrate that there is a hierarchical pre-
cordial lead distribution of DF with values decreasing away 
from the lead closest to the arrhythmogenic substrate location. 
Together, the hierarchical distribution of precordial phases 
and DFs suggests that the mechanism that sustains early VF 
can be attributed to relatively small number of high-frequency 
sources that could be targeted more effectively with noninva-
sive guidance.
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SUPPLEMENTAL MATERIAL 
 
Supplemental Methods 
Patients 
Patients were admitted for electrophysiology (EP) study with either Brugada Syndrome 
(BrS) or Ischemic Cardiomyopathy (IC). The goal in the BrS cohort was to assess the 
risk profile according to the clinical standards that recommended testing for inducibility 
of sustained VF in patients displaying spontaneous type-I ECG pattern. The IC cohort 
conformed to patients with healed myocardial infarction (MI, >6 months) and sustained 
ventricular tachycardia (VT) that were admitted to our institutions for a catheter based 
ablation procedure. The study was approved by the Ethics Committee and subjects 
gave informed consent. 
 
Electrophysiology and Recording Protocol 
EP Study was performed in the fasting, unsedated state. All antiarrhythmic drugs were 
discontinued prior to study. In all patients x12 lead standard ECG was recorded 
continuously at 1 KHz sampling rate and 0.05-150 Hz band-pass filtering. The EP 
strategy varied according to the clinical indication as follows: 
i) Brugada syndrome patients: programmed stimulation was used to induce VF. A 
tetrapolar catheter was positioned in the right ventricular apex (RVA). A second 
catheter at the right ventricular outflow tract (RVOT) was considered optional. 
Programed ventricular stimulation at the RVA was performed using trains of pulses 
with a basic cycle length of 600/400 ms, and up to 3 extra stimuli limited by tissue 
refractoriness or maximum coupling interval of 200 ms. If RVA stimulation failed to 
induce sustained VF, the protocol was repeated pacing from the RVOT. Patients were 
included in the study only if the immediately preceding ECG displayed a type-I ECG 
pattern on the right precordial leads (V1 and V2). 
ii) Ischemic cardiomyopathy patients: programmed stimulation was used to induce 
VT (VF induction was unintentional by protocol). A tetrapolar catheter was placed in 
the RVA and a 3.5 mm irrigated tip catheter (Navistar Thermocool®, Biosense Webster) 
was placed in the left ventricle (LV) for endocardial mapping and ablation. The VT 
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ablation procedure included the following: 3D endocardial reconstructions were 
created by CARTO (Biosense Webster) delineating endocardial scar tissue as areas 
displaying bipolar electrogram amplitudes of <1.5 mV and dense scar tissue with 
electrogram amplitudes of <0.5 mV. Ablation followed mapping of induced and/or 
spontaneous sustained VT. Careful attention was paid to localize the exit site of the 
VT in relation to the myocardial scar. Areas displaying presystolic electrograms (within 
50 ms before the QRS onset) and fulfilling the criteria of concealed entrainment with 
equally spike-QRS to electrogram-QRS intervals were considered at the tachycardia 
exit site and annotated in the 3D maps. When no sustained VT was inducible, or fast 
VT induction required cardioversion, a substrate-based ablation was performed 
consisting of RF ablation and elimination of delayed electrograms in the scar areas as 
described.1 The IC patients included in the study were those in whom sustained VF 
was unintentionally induced, either by pacing or while moving the catheters. In a subset 
of 6 patients, CT-Scan images were merged with the CARTO mapping for better 
anatomical reference. The positions of the precordial ECG leads at the thorax surface 
were marked by acquiring the corresponding location of catheter tip points on the 
CARTO. Continuous pacing from the RVOT and RVA was performed to allow for 
controlled origin of propagated waves and validation of methods. 
 
Processing of Precordial ECG Signals 
ECG signals from precordial V1-V6 leads (Figure S2) were exported for off-line 
analysis. VF and VT were classified based on the morphology of the surface recordings 
and the regularity of bipolar signals from the right and left ventricular endocardium. 
Precordial signals were processed by a Hanning window and with a non-biased 1-20 
Hz band-pass filter to minimize baseline wander and high-frequency harmonics 
(Sigview® v2.3, SignalLab). Thereafter, a 4096-point fast Fourier transformation (FFT, 
spectral resolution 0.24 Hz) was obtained for frequency and phase analysis. Power 
and phase versus frequency were calculated for sliding episodes with 15 ms leaps 
(periodograms). Dominant frequency (DF) was defined as the frequency of highest 
power in the power spectrum. Power spectra obtained by FFT for the 6 precordial leads 
were also analyzed for spatiotemporal patterns across time. A shared frequency (SF) 
was defined as a frequency with power peak lasting more than 0.5 sec concurrently in 
all leads (Figure 1). The life-span of the SF was quantified as the time interval between 
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its appearance and disappearance as a discrete power peak in the periodogram of all 
precordial leads. Phase was calculated by two methods, as follows: (i) the 
instantaneous phase at the SF was calculated based on the ratio of the imaginary to 
the real components of the FFT at the SF frequency of the sliding episodes; (ii) the 
instantaneous phase of the activity, considering its entire frequency spectrum, was 
calculated based on its Hilbert transform.2 The calculated phases were plotted against 
the time of the sliding episodes for all the precordial leads (Figure 2 and Figure S2). 
The time-course of the phases in each precordial lead enabled the analysis of their 
relative timing and sequence of activation. The phase time-courses of the leads during 
VF and VT were found to cluster in groups separated by periodic intervals that were 
>50% longer than the 2nd ranked intervals (Figure 2). Two characteristics of the phase 
clusters were quantified: first, for the instantaneous distribution of the level of activity 
across leads, we determined the phase distribution at a particular time as early (top) 
to late (bottom, Figure 2 panel A; black arrow); Second, for the propagation of the 
activity across leads we determined progression of time for a fixed phase (Phase 
propagation; Figure 2, panel A; red arrow). 
 
Computer Simulations 
Simulated body surface potentials during ventricular pacing were computed for 
validation in a 3D realistic model of human heart and torso. The ventricular model3 was 
segmented from a human diffusion tensor magnetic resonance imaging (DTMRI) 
dataset with hexahedral elements 0.5 mm size (1.43 million nodes). ten Tusscher et al 
membrane kinetics4 were used to simulate heterogeneous action potentials and 
excitation propagation using an operator splitting method with adaptive time step 
(>0.02 ms). The human torso was segmented from magnetic resonance data 
considering bone, muscle, blood, lung and liver properties. The inhomogeneous torso 
consisted of 134,600 nodes and 755,394 tetrahedrons, with a mean distance of 0.6 cm 
between nodes.5 
 
Statistical Analysis 
Continuous variables are reported as meanstandard deviation (SD) or followed by 
95% Confidence Interval (CI95%). Categorical variables are reported as number and 
4 
 
percentage. In the case of nondependent variables we used the Chi-Square test 
(categorical variables) and unpaired or pairwise t-test (continuous variables) for 
comparisons as appropriate. Pearson’s coefficient is also used to compute linear 
correlation in the case of nondependent data. Kernel density estimator is used to 
estimate de density function of data distribution when appropriate.6 The estimation is 
computed directly using the R "density" function (R version 3.1 [www.r-project.org]) 
and the used kernel is Gaussian. 
 
Resampling methods have been used to make inferences when dealing with complex 
data structures; e.g., where different observations could be drawn from the same 
subject (dependency structures). Specifically, the naive bootstrap7 and the general 
bootstrap algorithm (gBA)8 were used for confidence intervals and testing, 
respectively. In both cases, the resampling was made on the subjects. In this context, 
correlation coefficients were calculated based on general additive models and taking 
into account the dependent data structure. The concordance correlation coefficient (ƙ 
coefficient) was computed when appropriate with CI95%: also computed by resampling 
methods. Analyses were performed with R version 3.1 (www.r-project.org), Origin 8.1 
(OriginLab Corp, Northampton, MA) and Matlab R2014a (Mathworks, Natick, MA). 
Statistical significance was established at p<0.05. 
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Supplemental Figures 
 
Figure S1 
 
 
 
Localization of the precordial leads, scar tissue and exit sites using the Electro-
anatomical mapping system. A. Acquisition of the precordial leads spatial location. The 
yellow arrow points to the tip of the CARTO catheter in contact with the precordial lead 
V2 to acquire its location for display in 3D maps as shown in Panel D. B. Illustration of 
the quantification of the scar tissue location on a short-axis of magnetic resonance 
image of the thorax. The X-Z coordinates of the scar points (bipolar < 0.5 mV) were 
exported from the 3D navigation system for every patient. A cross-patient invariable 
origin of the coordinate system was localized to 0.35 distance units to the left of the 
most right aspect of the LV (X=0) and the most posterior aspect of the LV (Z=0) for 
each patient (a location corresponding to the mid-basal aspect of the LV). The angle 
of each scar point (azimuth) was then calculated as arctan(Z/X), independently from 
6 
 
the heart size of each patient. For illustration, 3 sample points at Septum, LV Apex and 
LV Infero-Lateral wall were marked with their distance vectors in the common 
coordinate system denote an increase in the angle displayed as they change in position 
from the lateral to the apex and the septal aspects of the LV. In addition, the projection 
of the 6 precordial leads on the same (X,Z) plane was used for the calculation of the 
angle of the leads (Panel D). C. The (X,Z) plane azimuth for 362 scars points classified 
each one prior to the angle calculation as being part of antero-septal, apex-posterior 
or infero-lateral scars in a subset of 6 patients for whom the position of the precordials 
were also recorded from the 3D navigation system. Box-plots depict the median, 25 
and 75 percentile. Dots outside the boxes are the outliers and bars represents the 
“inner fences”, which extend to 1.5 times the height of the box. The figure shows that 
despite physiological overlap between the 3 scar locations, their (X,Z) plane azimuths 
are distinguishable. Due to the complexity of the data structure and the sparse sample 
size available, in this analysis we only describe the results and refrain from a 
hypothesis testing and quantified probabilities (p-values) which do not provide 
additional information. D. The VT exit sites in 10 patients are superimposed on a 
reference individual endocardial map displaying also the precordial leads position. The 
incorporation of exits sites on a common map was used for the calculation of the exits 
sites and precordial azimuths in the same coordinates system. 
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Figure S2 
 
 
 
Concordance between the precordial leads origin obtained thorough FFT- and Hilbert-
based phase propagation analysis during VF. The concordance correlation coefficient 
(ƙ coefficient) observed between both methods (FFT vs. Hilbert Phase) was 0.741 
(CI95%: 0.497-0.938; computed by resampling methods). A. Distribution of data in 
BrSugada Syndrome patients. B. Distribution of data in Ischemic Cardiomyopathy 
patients. 
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Figure S3 
 
 
 
A representative example of the phase approach applied to a monomorphic VT. A. 
Precordial ECG tracings of the mapped VT. B. Time course of FFT-based phase at 2.2 
Hz (the VT frequency). Black arrow denotes the sequence of phases from V1 to V6 at 
a fixed time. Red arrow indicates phase propagation across leads and time. C. 3D map 
displaying the RV, LV and superimposed color-coded phase distribution map in the 
precordial leads (timed at the black arrow in panel B). The VT exit site is marked with 
red dots at the high and basal LV septum. D. Phase propagation diagram denotes 
time-independent activation sequence from V1 to V6. Overall, the phase distribution 
and propagation is in agreement with what is expected from the exit site of the VT as 
illustrated in Panel C and D. 
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Figure S4 
 
 
Validation of the phase analysis using computer simulations. A. A realistic computer 
model of human ventricles and torso was used to simulate ventricular wave 
propagation and precordial lead ECGs during pacing. The right side traces show 
simulated ECG signals at the indicated pacing and recording sites. B. Pacing from 
septal (1), apex (2) and lateral (3) ventricular sites resulted in varying sequences of 
phase distribution across the precordial leads. Black arrows depict the distribution of 
phases from early to late at a sample instant. C. Plots of phase/time (white arrows) vs. 
lead number (black arrows) show phase propagation. The direction of propagation of 
FFT phases during pacing shows dependency on the directionality of wavefront 
propagation. Septal pacing (left) results in a V1 to V5-V6 propagation; LV lateral pacing 
(right) reverses propagation from V5-V6 to V1. LV apex pacing (middle) results in 
propagation toward V1 and V6. AU: arbitrary units. 
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Figure S5 
 
Phase analysis for waves originating at the same scar, but propagating in opposite 
directions (opposite exit sites). A. Top, views of the ventricles with conduction block 
lines (red lines) modeling scars of typical sizes in the septum and lateral aspects of the 
LV. Pacing is on either side of the block line (green dots) to simulate waves originating 
at those scars, but moving in opposite directions. Bottom, basal view of the models 
with color-coded transmembrane potential for the four pacing sites. Tracking the wave 
propagation for each block line reveals that following a brief period in which waves 
moved in opposite directions (yellow arrows at 100 ms), the subsequent pattern of 
wave of propagation ended up being similar irrespective of the initial exit site (yellow 
arrows at 300 ms). B. Plots of phase/time (white arrows) vs. lead number (black 
arrows) reproduce the sequences observed in IC patients (Figures 3 and 4) and show 
that although phase propagation maps are somewhat sensitive to the particular 
direction of the waves at their exit sites, the general pattern of propagation is more 
strongly affected by the spatial location of the wave origin (V6 to V1 when the exit sites 
are on the lateral wall; V1 to V6 first when the exit sites are on the septum). 
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Figure S6 
 
Phase propagation of paced waves from two different locations in the right ventricle. 
A. 3D map of the right ventricle with the pacing sites at the apex (RVA) and the outflow 
tract (RVOT). B. Precordial ECG signals during high frequency pacing (cycle length 
200 ms) at the RVOT and the corresponding phase propagation diagrams. C. 
Precordial ECG signals during the same pacing frequency (cycle length 200 ms) at the 
RVA and the corresponding phase propagation diagrams. Despite limitations in the 
time domain analysis of the ECG tracings at high frequency, phase propagation 
sequence remains sensitive to the spatial location of the pacing site and to the 
myocardial patterns of propagation. 
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Figure S7 
 
 
 
Correlations between the (X,Z) plane angles (azimuths; see Figure S1) of the scar and 
VT exit site locations with the angle of the first precordial to be activated during VF and 
VT respectively. A. Correlation observed between the azimuth of 362 scar points in 6 
different patients and the azimuth of the first precordial being activated during VF (data 
from patients included in panel C of Figure S1). The Identity line (black) is very close 
to the linear best fit line (red line) and the identity line also falls well inside the 95% 
predictability line (magenta). Both facts corroborate the notion that the first precordial 
lead in the phase analysis can be used to guide for the location of the scar. Due to the 
complexity of the data structure and the sparse sample size available (N=6), in this 
analysis we report only 95% confidence intervals computed by resampling methods 
(omitting p-values). B. The azimuth in the (X,Z) plane for each VT exit site was 
correlated with the azimuth of the first precordial that is being activated at each cycle 
during VT. (Not to be confused with exit sites generating opposing wave propagation 
as simulated in Fig. S4) A significant correlation was observed, which enhances the 
significance of the phase-propagation patterns as dependent on the origin of the 
electrical propagation in the myocardium. 
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